Literature DB >> 9126657

Collagen-synthesizing cells in initial and advanced atherosclerotic lesions of human aorta.

E R Andreeva1, I M Pugach, A N Orekhov.   

Abstract

Accumulation of extracellular matrix, fibrosis, is regarded to be one of the major manifestations of atherosclerosis. Collagen type I is the predominant matrix component in human atherosclerotic plaques. In this work we have demonstrated procollagen type I expressing cells (PCI-cells) and studied their localization in grossly normal human aorta and atherosclerotic lesions: initial lesions, fatty streaks, fibrolipid lesions (fibrolipid plaque, fibroatheroma), fibrotic lesions (fibrous plaque). PCI-cells were revealed immunocytochemically using SPI.D8 monoclonal antibody against human procollagen type I. We failed to detect PCI-cells in the areas of grossly normal aorta and media underlying atherosclerotic lesions. Positively stained cells were shown in the areas of initial lesions, fatty streaks, fibrolipid and fibrous plaques. The largest amount of PCI-cells was revealed in fatty streaks. These cells were predominantly localized in the preluminal proteoglycan-rich intimal sublayer. Intimal cells in grossly normal regions formed a common cellular network contacting each other with their processes. The cellular network is found to be partly disintegrated in atherosclerotic lesions, which leads to the appearance of isolated cells. The share of isolated PCI-cells localized outside the intimal cellular network was higher in advanced lesions than in the areas of early atherosclerotic lesions. In initial lesions most of PCI-cells were identified as smooth muscle cells using antibodies to smooth muscle alpha-actin. In fatty streaks PCI-expressing smooth muscle cells were fewer in number. Much fewer cells double-stained with anti-alpha-actin and anti-PCI antibodies were found in fibrolipid and fibrous plaques. The proportion of these double stained cells was higher among total number of PCI-cells involved in the cellular network versus PCI-cells outside the network. The results of the study demonstrated that the most active de novo synthesis of interstitial collagen takes place in the regions of atherosclerotic lesions characterized by lipid deposition, which may lead to the further progression of atherosclerotic lesions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9126657     DOI: 10.1016/s0021-9150(96)06056-x

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  14 in total

1.  Intimal pericytes as the second line of immune defence in atherosclerosis.

Authors:  Ekaterina A Ivanova; Yuri V Bobryshev; Alexander N Orekhov
Journal:  World J Cardiol       Date:  2015-10-26

2.  Porphyromonas gingivalis accelerates inflammatory atherosclerosis in the innominate artery of ApoE deficient mice.

Authors:  Chie Hayashi; Jason Viereck; Ning Hua; Alkystis Phinikaridou; Andrés G Madrigal; Frank C Gibson; James A Hamilton; Caroline A Genco
Journal:  Atherosclerosis       Date:  2010-12-22       Impact factor: 5.162

3.  Imaging and quantitative analysis of atherosclerotic lesions by CARS-based multimodal nonlinear optical microscopy.

Authors:  Han-Wei Wang; Ingeborg M Langohr; Michael Sturek; Ji-Xin Cheng
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-06-11       Impact factor: 8.311

Review 4.  Harnessing Single-Cell RNA Sequencing to Better Understand How Diseased Cells Behave the Way They Do in Cardiovascular Disease.

Authors:  Farwah Iqbal; Adrien Lupieri; Masanori Aikawa; Elena Aikawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-17       Impact factor: 8.311

5.  NF-κB and matrix-dependent regulation of osteopontin promoter activity in allylamine-activated vascular smooth muscle cells.

Authors:  E Spencer Williams; Emily Wilson; Kenneth S Ramos
Journal:  Oxid Med Cell Longev       Date:  2012-01-22       Impact factor: 6.543

6.  Macrophages in immunopathology of atherosclerosis: a target for diagnostics and therapy.

Authors:  Alexander N Orekhov; Igor A Sobenin; Mikhail A Gavrilin; Alexei Gratchev; Svetlana Y Kotyashova; Nikita G Nikiforov; Julia Kzhyshkowska
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

7.  Approach to reduction of blood atherogenicity.

Authors:  Alexander N Orekhov; Alexandra A Melnichenko; Igor A Sobenin
Journal:  Oxid Med Cell Longev       Date:  2014-06-29       Impact factor: 6.543

Review 8.  Quantitative assessment of heteroplasmy of mitochondrial genome: perspectives in diagnostics and methodological pitfalls.

Authors:  Igor A Sobenin; Konstantin Y Mitrofanov; Andrey V Zhelankin; Margarita A Sazonova; Anton Y Postnov; Victor V Revin; Yuri V Bobryshev; Alexander N Orekhov
Journal:  Biomed Res Int       Date:  2014-04-10       Impact factor: 3.411

Review 9.  Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease.

Authors:  Alexander N Orekhov; Yuri V Bobryshev; Igor A Sobenin; Alexandra A Melnichenko; Dimitry A Chistiakov
Journal:  Int J Mol Sci       Date:  2014-07-21       Impact factor: 5.923

Review 10.  Monocyte Activation in Immunopathology: Cellular Test for Development of Diagnostics and Therapy.

Authors:  Ekaterina A Ivanova; Alexander N Orekhov
Journal:  J Immunol Res       Date:  2016-01-18       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.